CIK 0001478320
- Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- Operating
- EIN
- 270907024
- Phone
- +1 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- 4 Exercise or conversion Chief Commercial Officer, MRD acquired 5,000 shares (option exercise)
- 4 Planned sale SVP and General Counsel sold 26,922 shares at $4.50 ($121,079)
- 4 Grant or award Chief Financial Officer acquired 31,260 shares (grant or award)
- 4 Exercise or conversion Director acquired 15,000 shares (option exercise)
- 4 Grant or award Director acquired 31,328 shares (grant or award)
- 4 Grant or award Director acquired 31,328 shares (grant or award)
- 4 Grant or award Director acquired 31,328 shares (grant or award)
- 4 Grant or award Director acquired 31,328 shares (grant or award)
- 4 Grant or award Director acquired 31,328 shares (grant or award)
- 4 Open-market sale Principal Accounting Officer sold 7,727 shares at $3.43 ($26,504)
- 4 Open-market sale SVP and General Counsel sold 13,381 shares at an average $3.43 ($45,963)
- 4 Open-market sale Chief People Officer sold 14,700 shares at an average $3.43 ($50,439)
- 4 Open-market sale Chief Commercial Ofc Imm Med sold 29,390 shares at an average $3.44 ($100,994)
- 4 Open-market sale President sold 39,070 shares at an average $3.47 ($135,764)
- 4 Grant or award Chief Scientific Officer acquired 354,610 shares (grant or award)
- 4 Open-market sale Chief Financial Officer sold 15,456 shares at $3.44 ($53,169)
- 4 Open-market sale CEO and Chairman sold 48,673 shares at an average $3.43 ($167,007)
- 4 Open-market sale Chief Commercial Officer, MRD sold 12,991 shares at an average $3.44 ($44,629)
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion Director acquired 100,000 shares (option exercise)
Page 7 of 28 · 544 filings